StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of Sorrento Therapeutics stock remained flat at $0.01 during trading on Friday. The company had a trading volume of 46,614 shares, compared to its average volume of 110,745. The business’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.02. Sorrento Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.25.
About Sorrento Therapeutics
Recommended Stories
- Five stocks we like better than Sorrento Therapeutics
- Best Aerospace Stocks Investing
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- ESG Stocks, What Investors Should Know
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Options Trading – Understanding Strike Price
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.